Why the study?
Does plasma propranolol concentration correlate with therapeutic response (exercise performance) in patients with angina pectoris?
Does plasma propranolol concentration correlate with therapeutic response (exercise performance) in patients with angina pectoris?
Answers are grounded in this paper and cite their sources.
Maximum therapeutic response to propranolol in angina patients occurs at 64-98% of total beta-adrenergic blockade, corresponding to average doses of 144 mg/day and plasma concentrations of 30 ng/ml.
The therapeutic response to propranolol was evaluated in patients with documented coronary artery disease at doses varying from 40 to 320 mg/day. Therapeutic response was quantified by evaluating exercise performance on a treadmill and then related to plasma propranolol concentration. Plasma propranolol was defined in terms of beta-adrenergic blockade by comparison with dose (concentration) response curves in normal subjects. Individual therapeutic benefit occurred at doses which averaged 144 +/- 21 mg/day and at concentrations which averaged 30 +/- 7 ng/ml. There was a wide variation between both dose and concentration among the patients at maximum therapeutic response, but when the plasma propranolol was related to pharmacologic activity, the maximum therapeutic response was observed between 64 to 98% of total blockade. Despite the increased exercise performance in these patients, the double product of heart rate and systolic blood pressure was always less, suggesting either an alteration of the relation between myocardial oxygen consumption and the double product during propranolol or a reduction on oxygen delivery to the myocardium as the result of beta-adrenergic blockade of the coronary vasculature.
No takes yet. Share an insight, caveat, or question.
Pine et al. (1975) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: